Salivary Oxytocin Levels in Children With and Without Autism: Group Similarities and Subgroup Variability

<b>Background:</b> Oxytocin (OXT), a neuropeptide involved in social bonding, has been proposed as a potential biomarker for autism spectrum disorder (ASD) due to its role in modulating social behaviors. However, prior studies on peripheral OXT levels in individuals with ASD have yielded inconsistent results, partly due to methodological and developmental variability. This study aimed to compare baseline salivary OXT concentrations between children with ASD and typically developing controls. <b>Methods:</b> In this cross-sectional, case-control study, salivary OXT levels were measured in 35 children aged 6-9 years (18 with ASD, 17 controls) using a standardized ELISA protocol. Samples were collected under controlled conditions and analyzed in duplicate. Between-group differences in raw and log-transformed OXT levels were examined using <i>t</i>-tests. Subgroup analyses were conducted by sex, and correlations with autism symptom severity (Aberrant Behavior Checklist, ABC) were assessed within the ASD group. <b>Results:</b> Children with ASD showed higher mean salivary OXT levels than controls (21.5 pg/mL vs. 14.0 pg/mL), but the difference was not statistically significant (Welch's t = -1.79, <i>p</i> = 0.088). Log transformation of OXT values confirmed the non-significant group difference (t = 1.68, <i>p</i> = 0.102). Female participants with ASD had significantly higher OXT than female controls (<i>p</i> = 0.048), while no difference was observed among males. OXT levels did not significantly correlate with autism severity (r = -0.04, <i>p</i> = 0.88). <b>Conclusions:</b> Baseline salivary OXT levels do not significantly differ between children with and without ASD and do not correlate with behavioral symptom severity. However, elevated OXT in females with ASD warrants cautious interpretation and further investigation. Salivary OXT may not be a reliable standalone diagnostic biomarker but could have exploratory value for understanding sex-specific neurobiological profiles in autism.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Medicine
Published
2025-09-24
DOI
https://doi.org/10.3390/jcm14196760
Citations
1
Primary Topic
Neuroendocrine regulation and behavior
Type
article
Field-Weighted Citation Impact
2.44
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Salivary Oxytocin Levels in Children With and Without Autism: Group Similarities and Subgroup Variability

Selami Varol Ülker, S. Kenan Köse, Sultan Tarlacı, Metin Çınaroğlu et al.
1 citations
Journal of Clinical Medicine
Neuroendocrine regulation and behavior
2.44
article

Salivary Oxytocin Levels in Children With and Without Autism: Group Similarities and Subgroup Variability

Selami Varol Ülker, S. Kenan Köse, Sultan Tarlacı, Metin Çınaroğlu, Eda Yılmazer
article en
1 citations

Abstract

<b>Background:</b> Oxytocin (OXT), a neuropeptide involved in social bonding, has been proposed as a potential biomarker for autism spectrum disorder (ASD) due to its role in modulating social behaviors. However, prior studies on peripheral OXT levels in individuals with ASD have yielded inconsistent results, partly due to methodological and developmental variability. This study aimed to compare baseline salivary OXT concentrations between children with ASD and typically developing controls. <b>Methods:</b> In this cross-sectional, case-control study, salivary OXT levels were measured in 35 children aged 6-9 years (18 with ASD, 17 controls) using a standardized ELISA protocol. Samples were collected under controlled conditions and analyzed in duplicate. Between-group differences in raw and log-transformed OXT levels were examined using <i>t</i>-tests. Subgroup analyses were conducted by sex, and correlations with autism symptom severity (Aberrant Behavior Checklist, ABC) were assessed within the ASD group. <b>Results:</b> Children with ASD showed higher mean salivary OXT levels than controls (21.5 pg/mL vs. 14.0 pg/mL), but the difference was not statistically significant (Welch's t = -1.79, <i>p</i> = 0.088). Log transformation of OXT values confirmed the non-significant group difference (t = 1.68, <i>p</i> = 0.102). Female participants with ASD had significantly higher OXT than female controls (<i>p</i> = 0.048), while no difference was observed among males. OXT levels did not significantly correlate with autism severity (r = -0.04, <i>p</i> = 0.88). <b>Conclusions:</b> Baseline salivary OXT levels do not significantly differ between children with and without ASD and do not correlate with behavioral symptom severity. However, elevated OXT in females with ASD warrants cautious interpretation and further investigation. Salivary OXT may not be a reliable standalone diagnostic biomarker but could have exploratory value for understanding sex-specific neurobiological profiles in autism.

Journal of Clinical MedicineVol. 14(19)
Üsküdar University (TR), Türkisch-Deutsche Universität (TR), Beykoz Üniversitesi (TR), Istanbul University (TR)
Openalex Percentile: Top 10%
Neuroendocrine regulation and behavior
2.44
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.